Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist, and Executive Director of Employer Services at the City of Hope Comprehensive Cancer Center in Duarte, CA.
Here's a recent video podcast I just did on the publication just out in Lancet Oncology, describing a randomized phase II study led by my friend Pasi Janne, from Dana Farber Cancer Institute in Boston.
[powerpress]
We've touched on this study before, but it's promising enough for the field of lung cancer that it should be covered as the publication comes out, especially since KRAS mutations are actually the most common molecular defect we see in NSCLC, and yet we haven't had an actual treatment to offer such patients in the past. Let's hope this work leads that to change soon.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi Wyde, Welcome to Grace. I'm so sorry you have to be here and hope you can connect with others. You ARE a unicorn as you have certainly found. I'm glad...
I hope you found this page about the live forum already. It's tomorrow 9am eastern time.
Hi Missy and welcome to Grace. I'm sorry you're going through this worry. As you have already heard a 6mm ggo that doesn't change isn't uncommon. Your pulmonologist may want to...
Recent Comments
Thank you for…
Hello and welcome to Grace. I'm sorry you need to look for this info. Stage IV rectal cancer survival rate depends on whether cancer is contained regionally or has spread to...